ArticleFrontiers in oncology2023

Detectable ctDNA at the time of treatment cessation of ipilimumab and nivolumab for toxicity predicts disease progression in advanced melanoma patients.

Lydia Warburton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.